Pre-tax margin is the percentage of revenue left as profit after every expense except income tax. It is income before income tax divided by revenue, and the table shows both amounts beside the percentage. It sits between operating margin and net margin: it includes interest and other non-operating items but not the tax charge, so the gap down to net margin is the tax burden. Quarterly and annual points each use the amounts filed for that same period, so a single quarter can swing with the seasons.
UroGen Pharma Ltd. pre-tax margin for the quarter ending 2026-06-30 was -12.04%, a change of 190.01% year-over-year.
UroGen Pharma Ltd. pre-tax margin for the quarter ending 2026-03-31 was -55.63%, a change of 158.91% year-over-year.
UroGen Pharma Ltd. pre-tax margin for the quarter ending 2025-12-31 was -70.40%, a change of 71.52% year-over-year.
UroGen Pharma Ltd. pre-tax margin for the quarter ending 2025-09-30 was -125.18%, a change of -31.61% year-over-year.
UroGen Pharma Ltd. pre-tax margin for fiscal 2025 was -139.74%, a change of -2.52% from fiscal 2024.
UroGen Pharma Ltd. pre-tax margin for fiscal 2024 was -137.22%, a change of -18.34% from fiscal 2023.
UroGen Pharma Ltd. pre-tax margin for fiscal 2023 was -118.87%, a change of 48.98% from fiscal 2022.
UroGen Pharma Ltd. pre-tax margin for fiscal 2022 was -167.86%, a change of 59.80% from fiscal 2021.